Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors.
about
Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma.Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acidsEpigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell typesNKG2D Ligands-Critical Targets for Cancer Immune Escape and Therapy
P2860
Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Impaired NK cell recognition o ...... istone deacetylase inhibitors.
@en
Impaired NK cell recognition o ...... istone deacetylase inhibitors.
@nl
type
label
Impaired NK cell recognition o ...... istone deacetylase inhibitors.
@en
Impaired NK cell recognition o ...... istone deacetylase inhibitors.
@nl
prefLabel
Impaired NK cell recognition o ...... istone deacetylase inhibitors.
@en
Impaired NK cell recognition o ...... istone deacetylase inhibitors.
@nl
P2093
P2860
P1433
P1476
Impaired NK cell recognition o ...... istone deacetylase inhibitors.
@en
P2093
Annette Paschen
Carmen Campos-Silva
Eva M García-Cuesta
Hugh T Reyburn
Natalia Pieper
Sheila López-Cobo
P2860
P304
P356
10.1080/2162402X.2017.1392426
P577
2017-11-06T00:00:00Z